Document ID: FDA-2012-N-0001-0012
Agency: fda
Document Type: Notice
Title: Blood Products Advisory Committee Meeting; Cancellation
Posted Date: 2012-02-13T05:00Z

[Federal Register Volume 77, Number 29 (Monday, February 13, 2012)]
[Notices]
[Pages 7588-7589]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-3199]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0001]

Blood Products Advisory Committee; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The meeting of the Blood Products Advisory Committee scheduled 
for February 29, 2012 is cancelled. This meeting was announced in the 
Federal Register of January 30, 2012 (77 FR 4567). FDA intends to 
convene at a future date a public scientific workshop to discuss the 
evaluation of possible new plasma products manufactured following 
storage at room temperature for up to 24 hours.

FOR FURTHER INFORMATION CONTACT: Bryan Emery or Pearl Muckelvene,

[[Page 7589]]

Center for Biologics Evaluation and Research (HFM-71), Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852, Contact 1-
301-827-1277 or 1-301-827-1281, or FDA Advisory Committee Information 
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), and 
follow the prompts to the desired center or product area. Please call 
the Information Line for up-to-date information on this meeting.

    Dated: February 7, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2012-3199 Filed 2-10-12; 8:45 am]
BILLING CODE 4160-01-P